# Kelix bio (Malta) Ltd. – FDA Inspection, Dec 16, 2022

Source: https://www.keypedia.com/records/fda_inspections/kelix-bio-malta-ltd/4f1c29ce-6b07-4fdb-8263-4efb10882a95
Source feed: FDA_Inspections

> FDA inspection 1192875 of Kelix bio (Malta) Ltd., December 16, 2022. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 211. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1192875
- Company Name: Kelix bio (Malta) Ltd.
- Inspection Date: 2022-12-16
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 4

## Related Documents

- [FDA Inspection 1089383 - 2019-05-03](https://www.keypedia.com/records/fda_inspections/kelix-bio-malta-ltd/f8a23e64-4bb7-49fc-844b-709712d90479)
- [FDA Inspection 1041539 - 2018-02-20](https://www.keypedia.com/records/fda_inspections/kelix-bio-malta-ltd/b0fe3c1c-fc44-4fbe-bc76-3379a8bee8c4)

Company: https://www.keypedia.com/companies/kelix-bio-malta-ltd/3595e81b-9a31-4dcc-b529-e58034aabdf7

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c